Author name: TB Alliance

The TB Alliance is pleased to welcome Johnson & Johnson to the select group of companies and organizations working diligently

Next generation of drugs perform well against resistant strains. Tuberculosis kills 2 million people a year, but a promising drug

Nicholas Johnson nearly died from what he thought was a shoulder sprain. Last year the 13-year-old from Stafford, Texas, made

“It’s time for TB patients to push for action on the research side. We need to say, ‘Look, we are

World Health Organization (WHO): “Priority Medicines for Europe and the World” This report, launched at the conference on “Priority Medicines

After three and a half years of dedicated service as the Director of Advocacy and Public Affairs at the TB

IN MEMORIAMJohn R. La Montagne, Ph.D.,NIAID Deputy DirectorSecretary, TB Alliance Board of Directors1943 – 2004 Dr. John La Montagne, deputy

[SINGAPORE] The Novartis Institute for Tropical Diseases (NITD) and the Global Alliance for Tuberculosis Drug Development (TB Alliance) have announced

Tuberculosis (TB) is the world’s oldest known infectious disease and the one that kills the most people today, about two

The Global Alliance for TB Drug Development plans to team up with a unit of Novartis AG to speed development